UNSPSC 51261504: Cetamolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H26N2O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5UNK5C6QM5, chemically known as 2-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenoxy)-n-methylacetamide monohydrochloride but more generally known as cetamolol hydrochloride, which bears US NIH Compound Identifier 53697. Most nations, for tariff and trade purposes, schedule cetamolol hydrochloride under HS 29242995 and SITC 51479.

As of Q4 2014, CETAMOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cetamolol hydrochloride bears US NLM identifiers UMLS ID C2825713 and NCI Concept Code C81652. SMILES: CC(C)(C)NCC(COC1CCCCC1OCC(=O)NC)O.CL.

UNSPSC 51261504 Cetamolol hydrochloride is a Commodity code that shows little relevant recent activity aligned with its nominal pharmaceutical scope. The most recent state and local opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—does not represent cetamolol procurement; instead, it reflects an acquisition of emergency response and harm-reduction supplies. State and local governments buying under pharmaceutical commodity codes typically source generic and brand-name medications through established health department, correctional facility, and public-health-agency channels, often via group purchasing agreements or standing competitive solicitations. The mismatch between the code designation and the actual scope of the Seminole County bid suggests either a coding error in the opportunity posting or a practice of broad pharmaceutical-category tagging that does not track specific active pharmaceutical ingredients.

Seminole County, Florida is the only recent issuing body on record. The IFB was posted on June 30, 2026, with a response deadline of July 26, 2023—a date inconsistency in the source that reflects posting lag or data error. The procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract structure includes an initial two-year term with a one-year renewal option, drug-free workplace and E-Verify compliance requirements, and standard insurance coverage provisions. No set-aside designations are noted. Until state and local procurement offices post additional cetamolol-specific solicitations, this code presents limited transparency into active buying patterns at the state and local level.